Updated Date:
30 Oct 2025
Product Detail:
TEPADINA thiotepa 400 mg powder for injection and solvent dual chamber infusion bag
Shortage Status:
Current
AUST R:
370354
Availability:
Unavailable
Active Ingredient:
thiotepa
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,powderfor
Supply Impact Dates
From 08 Jan 2024 To 01 Dec 2025
Management Action:
Other strengths are available.